Source: https://edoc.mdc-berlin.de/view/divisions/spuler.html
Timestamp: 2019-04-19 12:41:18+00:00

Document:
Exon skipping in a Dysf-missense mutant mouse model.
Malcher, J. and Heidt, L. and Goyenvalle, A. and Escobar, H. and Marg, A. and Beley, C. and Benchaouir, R. and Bader, M. and Spuler, S. and García, L. and Schöwel, V.
Teenage exercise is associated with earlier symptom onset in dysferlinopathy: a retrospective cohort study.
Moore, U.R. and Jacobs, M. and Fernandez-Torron, R. and Jang, J. and James, M.K. and Mayhew, A. and Rufibach, L. and Mittal, P. and Eagle, M. and Cnaan, A. and Carlier, P.G. and Blamire, A. and Hilsden, H. and Lochmüller, H. and Grieben, U. and Spuler, S. and Tesi Rocha, C. and Day, J.W. and Jones, K.J. and Bharucha-Goebel, D.X. and Salort-Campana, E. and Harms, M. and Pestronk, A. and Krause, S. and Schreiber-Katz, O. and Walter, M.C. and Paradas, C. and Hogrel, J.Y. and Stojkovic, T. and Takeda, S. and Mori-Yoshimura, M. and Bravver, E. and Sparks, S. and Diaz-Manera, J. and Bello, L. and Semplicini, C. and Pegoraro, E. and Mendell, J.R. and Bushby, K. and Straub, V.
Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials.
Diaz-Manera, J. and Fernandez-Torron, R. and LLauger, J. and James, M.K. and Mayhew, A. and Smith, F.E. and Moore, U.R. and Blamire, A.M. and Carlier, P.G. and Rufibach, L. and Mittal, P. and Eagle, M. and Jacobs, M. and Hodgson, T. and Wallace, D. and Ward, L. and Smith, M. and Stramare, R. and Rampado, A. and Sato, N. and Tamaru, T. and Harwick, B. and Rico Gala, S. and Turk, S. and Coppenrath, E.M. and Foster, G. and Bendahan, D. and Le Fur, Y. and Fricke, S.T. and Otero, H. and Foster, S.L. and Peduto, A. and Sawyer, A.M. and Hilsden, H. and Lochmuller, H. and Grieben, U. and Spuler, S. and Tesi Rocha, C. and Day, J.W. and Jones, K.J. and Bharucha-Goebel, D.X. and Salort-Campana, E. and Harms, M. and Pestronk, A. and Krause, S. and Schreiber-Katz, O. and Walter, M.C. and Paradas, C. and Hogrel, J.Y. and Stojkovic, T. and Takeda, S. and Mori-Yoshimura, M. and Bravver, E. and Sparks, S. and Bello, L. and Semplicini, C. and Pegoraro, E. and Mendell, J.R. and Bushby, K. and Straub, V.
Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy.
Iannotti, F.A. and Pagano, E. and Guardiola, O. and Adinolfi, S. and Saccone, V. and Consalvi, S. and Piscitelli, F. and Gazzerro, E. and Busetto, G. and Carrella, D. and Capasso, R. and Puri, P.L. and Minchiotti, G. and Di Marzo, V.
Muscle atrophy due to nerve damage is accompanied by elevated myofibrillar protein synthesis rates.
Langer, H.T. and Senden, J.M.G. and Gijsen, A.P. and Kempa, S. and van Loon, Luc J. C. and Spuler, S.
Burst-like transcription of mutant and wildtype MYH7-alleles as possible origin of cell-to-cell contractile imbalance in hypertrophic cardiomyopathy.
Montag, J. and Kowalski, K. and Makul, M. and Ernstberger, P. and Radocaj, A. and Beck, J. and Becker, E. and Tripathi, S. and Keyser, B. and Mühlfeld, C. and Wissel, K. and Pich, A. and van der Velden, J. and Dos Remedios, C.G. and Perrot, A. and Francino, A. and Navarro-López, F. and Brenner, B. and Kraft, T.
Meraviglia, V. and Benzoni, P. and Landi, S. and Murano, C. and Langione, M. and Motta, B.M. and Baratto, S. and Silipigni, R. and Di Segni, M. and Pramstaller, P.P. and DiFrancesco, D. and Gazzerro, E. and Barbuti, A. and Rossini, A.
An eicosanoid protects from statin-induced myopathic changes in primary human cells.
Grunwald, S. and Popp, O. and Haafke, S. and Jedraszczak, N. and Grieben, U. and Saar, K. and Patone, G. and Kress, W. and Steinhagen-Thiessen, E. and Dittmar, G. and Spuler, S.
Master and commander? FoxO's role in muscle atrophy.
Loss of Ptpn11 (Shp2) drives satellite cells into quiescence.
Griger, J. and Schneider, R. and Lahmann, I. and Schöwel, V. and Keller, C. and Spuler, S. and Nazare, M. and Birchmeier, C.
Localized irradiation of mouse legs using an image-guided robotic linear accelerator.
Kufeld, M. and Escobar, H. and Marg, A. and Pasemann, D. and Budach, V. and Spuler, S.
The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies.
Bhattarai, S. and Ghannam, K. and Krause, S. and Benveniste, O. and Marg, A. and de Bruin, G. and Xin, B.T. and Overkleeft, H.S. and Spuler, S. and Stenzel, W. and Feist, E.
FHL1B Interacts with lamin A/C and emerin at the nuclear lamina and is misregulated in Emery-Dreifuss Muscular Dystrophy.
Ziat, E. and Mamchaoui, K. and Beuvin, M. and Nelson, I. and Azibani, F. and Spuler, S. and Bonne, G. and Bertrand, A.T.
The clinical outcome study for dysferlinopathy: an international multicenter study.
Harris, E. and Bladen, C.L. and Mayhew, A. and James, M. and Bettinson, K. and Moore, U. and Smith, F.E. and Rufibach, L. and Cnaan, A. and Bharucha-Goebel, D.X. and Blamire, A.M. and Bravver, E. and Carlier, P.G. and Day, J.W. and Díaz-Manera, J. and Eagle, M. and Grieben, U. and Harms, M. and Jones, K.J. and Lochmüller, H. and Mendell, J.R. and Mori-Yoshimura, M. and Paradas, C. and Pegoraro, E. and Pestronk, A. and Salort-Campana, E. and Schreiber-Katz, O. and Semplicini, C. and Spuler, S. and Stojkovic, T. and Straub, V. and Takeda, S. and Rocha, C.T. and Walter, M.C. and Bushby, K.
Cardiac involvement in myotonic dystrophy type 2 patients with preserved ejection fraction: Detection by cardiovascular magnetic resonance.
Schmacht, L. and Traber, J. and Grieben, U. and Utz, W. and Dieringer, M.A. and Kellman, P. and Blaszczyk, E. and von Knobelsdorff-Brenkenhoff, F. and Spuler, S. and Schulz-Menger, J.
A molecular signature of myalgia in myotonic dystrophy 2.
Moshourab, R. and Palada, V. and Grunwald, S. and Grieben, U. and Lewin, G.R. and Spuler, S.
Full-length dysferlin transfer by the hyperactive Sleeping Beauty transposase restores dysferlin-deficient muscle.
Escobar, H. and Schöwel, V. and Spuler, S. and Marg, A. and Izsvák, Z.
Dysferlin rescue by spliceosome-mediated pre-mRNA trans-splicing targeting introns harbouring weakly defined 3' splice sites.
Philippi, S. and Lorain, S. and Beley, C. and Peccate, C. and Precigout, G. and Spuler, S. and Garcia, L.
Cavin 1 function does not follow caveolar morphology.
Timmel, T. and Kunz, S. and Seifert, F. and Schuelke, M. and Spuler, S.
Small molecules dorsomorphin and LDN-193189 inhibit myostatin/GDF8 signaling and promote functional myoblast differentiation.
Horbelt, D. and Boergermann, J.H. and Chaikuad, A. and Alfano, I. and Williams, E. and Lukonin, I. and Timmel, T. and Bullock, A.N. and Knaus, P.
Human satellite cells have regenerative capacity and are genetically manipulable.
Marg, A. and Escobar, H. and Gloy, S. and Kufeld, M. and Zacher, J. and Spuler, A. and Birchmeier, C. and Izsvák, Z. and Spuler, S.
Long term recovery in critical illness myopathy is complete, contrary to polyneuropathy.
Koch, S. and Wollersheim, T. and Bierbrauer, J. and Haas, K. and Mörgeli, R. and Deja, M. and Spies, C.D. and Spuler, S. and Krebs, M. and Weber-Carstens, S.
Lipid accumulation in dysferlin-deficient muscles.
Grounds, M.D. and Terrill, J. and Radley-Crabb, H. and Robertson, T. and Papadimitriou, J. and Spuler, S. and Shavlakadze, T.
Identifying dynamic membrane structures with atomic-force microscopy and confocal imaging.
Timmel, T. and Schuelke, M. and Spuler, S.
Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy.
Langhans, C. and Weber-Carstens, S. and Schmidt, F. and Hamati, J. and Kny, M. and Zhu, X. and Wollersheim, T. and Koch, S. and Krebs, M. and Schulz, H. and Lodka, D. and Saar, K. and Labeit, S. and Spies, C. and Hubner, N. and Spranger, J. and Spuler, S. and Boschmann, M. and Dittmar, G. and Butler-Browne, G. and Mouly, V. and Fielitz, J.
Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness.
Wollersheim, T. and Woehlecke, J. and Krebs, M. and Hamati, J. and Lodka, D. and Luther-Schroeder, A. and Langhans, C. and Haas, K. and Radtke, T. and Kleber, C. and Spies, C. and Labeit, S. and Schuelke, M. and Spuler, S. and Spranger, J. and Weber-Carstens, S. and Fielitz, J.
Altered expression of cyclin A 1 in muscle of patients with facioscapulohumeral muscle dystrophy (FSHD-1).
Pakula, A. and Schneider, J. and Janke, J. and Zacharias, U. and Schulz, H. and Hübner, N. and Mähler, A. and Spuler, A. and Spuler, S. and Carlier, P. and Boschmann, M.
Linking cytoarchitecture to metabolism: sarcolemma-associated plectin affects glucose uptake by destabilizing microtubule networks in mdx myofibers.
Raith, M. and Valencia, R.G. and Fischer, I. and Orthofer, M. and Penninger, J.M. and Spuler, S. and Rezniczek, G.A. and Wiche, G.
Critical illness myopathy and GLUT4 - significance of insulin and muscle contraction.
Weber-Carstens, S. and Schneider, J. and Wollersheim, T. and Assmann, A. and Bierbrauer, J. and Marg, A. and Al Hasani, H. and Chadt, A. and Wenzel, K. and Koch, S. and Fielitz, J. and Kleber, C. and Faust, K. and Mai, K. and Spies, C.D. and Luft, F.C. and Boschmann, M. and Spranger, J. and Spuler, S.
Schoewel, V. and Marg, A. and Kunz, S. and Overkamp, T. and Siegert Carrazedo, R. and Zacharias, U. and Daniel, P.T. and Spuler, S.
Sarcolemmal repair is a slow process and includes EHD2.
Marg, A. and Schoewel, V. and Timmel, T. and Schulze, A. and Shah, C. and Daumke, O. and Spuler, S.
Prediction of long-term outcome in glycine encephalopathy: a clinical survey.
Hennermann, J.B. and Berger, J.M. and Grieben, U. and Scharer, G. and Van Hove, J.L.K.
Dysferlin-deficient immortalized human myoblasts and myotubes as a useful tool to study dysferlinopathy.
Philippi, S. and Bigot, A. and Marg, A. and Mouly, V. and Spuler, S. and Zacharias, U.
Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane.
Bierbrauer, J. and Koch, S. and Olbricht, C. and Hamati, J. and Lodka, D. and Schneider, J. and Luther-Schroeder, A. and Kleber, C. and Faust, K. and Wiesener, S. and Spies, C.D. and Spranger, J. and Spuler, S. and Fielitz, J. and Weber-Carstens, S.
Ahnak1 abnormally localizes in muscular dystrophies and contributes to muscle vesicle release.
Zacharias, U. and Purfuerst, B. and Schoewel, V. and Morano, I. and Spuler, S. and Haase, H.
Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders.
Mamchaoui, K. and Trollet, C. and Bigot, A. and Negroni, E. and Chaouch, S. and Wolff, A. and Kandalla, P.K. and Marie, S. and Di Santo, J. and St Guily, J.L. and Muntoni, F. and Kim, J. and Philippi, S. and Spuler, S. and Levy, N. and Blumen, S.C. and Voit, T. and Wright, W.E. and Aamiri, A. and Butler-Browne, G. and Mouly, V.
STAT1 signaling is not regulated by a phosphorylation-acetylation switch.
Antunes, F. and Marg, A. and Vinkemeier, U.
Cytokine-induced paracrystals prolong the activity of signal transducers and activators of transcription (STAT) and provide a model for the regulation of protein solubility by small ubiquitin-like modifier (SUMO).
Droescher, M. and Begitt, A. and Marg, A. and Zacharias, M. and Vinkemeier, U.
Delay in diagnosis of muscle disorders depends on the subspecialty of the initially consulted physician.
Spuler, S. and Stroux, A. and Kuschel, F. and Kuhlmey, A. and Kendel, F.
Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge.
Koch, S. and Spuler, S. and Deja, M. and Bierbrauer, J. and Dimroth, A. and Behse, F. and Spies, C.D. and Wernecke, K.D. and Weber-Carstens, S.
Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1.
Biedasek, K. and Andres, J. and Mai, K. and Adams, S. and Spuler, S. and Fielitz, J. and Spranger, J.
Deuschl, G. and Margraf, N. and Spuler, S. and Kupsch, A. and Schulz-Schaeffer, W.J.
Clinical features of facioscapulohumeral muscular dystrophy 2.
de Greef, J.C. and Lemmers, R.J. and Camano, P. and Day, J.W. and Sacconi, S. and Dunand, M. and van Engelen, B.G. and Kiuru-Enari, S. and Padberg, G.W. and Rosa, A.L. and Desnuelle, C. and Spuler, S. and Tarnopolsky, M. and Venance, S.L. and Frants, R.R. and van der Maarel, S.M. and Tawil, R.
Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study.
Weber-Carstens, S. and Deja, M. and Koch, S. and Spranger, J. and Bubser, F. and Wernecke, K.D. and Spies, C.D. and Spuler, S. and Keh, D.
Myopathy causing camptocormia in idiopathic Parkinson's disease: a multidisciplinary approach.
Spuler, S. and Krug, H. and Klein, C. and Medialdea, I.C. and Jakob, W. and Ebersbach, G. and Gruber, D. and Hoffmann, K.T. and Trottenberg, T. and Kupsch, A.
Another side to statin-related side effects.
Knoblauch, H. and Schoewel, V. and Kress, W. and Rosada, A. and Spuler, S.
LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance.
Boschmann, M. and Engeli, S. and Moro, C. and Luedtke, A. and Adams, F. and Gorzelniak, K. and Rahn, G. and Maehler, A. and Dobberstein, K. and Krueger, A. and Schmidt, S. and Spuler, S. and Luft, F.C. and Smith, S.R. and Schmidt, H.H. and Jordan, J.
Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations.
Rajab, A. and Straub, V. and McCann, L.J. and Seelow, D. and Varon, R. and Barresi, R. and Schulze, A. and Lucke, B. and Luetzkendorf, S. and Karbasiyan, M. and Bachmann, S. and Spuler, S. and Schuelke, M.
Cardiac involvement in sporadic inclusion-body myositis.
Utz, W. and Schmidt, S. and Schulz-Menger, J. and Luft, F. and Spuler, S.
Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy.
Gueneau, L. and Bertrand, A.T. and Jais, J.P. and Salih, M.A. and Stojkovic, T. and Wehnert, M. and Hoeltzenbein, M. and Spuler, S. and Saitoh, S. and Verschueren, A. and Tranchant, C. and Beuvin, M. and Lacene, E. and Romero, N.B. and Heath, S. and Zelenika, D. and Voit, T. and Eymard, B. and Ben Yaou, R. and Bonne, G.
Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients.
Weber-Carstens, S. and Koch, S. and Spuler, S. and Spies, C.D. and Bubser, F. and Wernecke, K.D. and Deja, M.
Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21.
Mai, K. and Andres, J. and Biedasek, K. and Weicht, J. and Bobbert, T. and Sabath, M. and Meinus, S. and Reinecke, F. and Moehlig, M. and Weickert, M.O. and Clemenz, M. and Pfeiffer, A.F. and Kintscher, U. and Spuler, S. and Spranger, J.
Amyloidose bei Muskeldystrophie [Amyloidosis in muscular dystrophy].
Carl, M. and Roecken, C. and Spuler, S.
Dysferlin-deficient muscular dystrophy: Gadofluorine M suitability at MR imaging in a mouse model.
Schmidt, S. and Vieweger, A. and Obst, M. and Mueller, S. and Gross, V. and Gutberlet, M. and Steinbrink, J. and Taubert, S. and Misselwitz, B. and Luedemann, L. and Spuler, S.
Wenzel, K. and Geier, C. and Qadri, F. and Huebner, N. and Schulz, H. and Erdmann, B. and Gross, V. and Bauer, D. and Dechend, R. and Dietz, R. and Osterziel, K.J. and Spuler, S. and Oezcelik, C.
Peroxisome proliferator-activated receptor-gamma C190S mutation causes partial lipodystrophy.
Luedtke, A. and Buettner, J. and Wu, W. and Muchir, A. and Schroeter, A. and Zinn-Justin, S. and Spuler, S. and Schmidt, H.H. and Worman, H.J.
Muscle and nerve pathology in Dunnigan familial partial lipodystrophy.
Spuler, S. and Kalbhenn, T. and Zabojszcza, J. and van Landeghem, F.K. and Ludtke, A. and Wenzel, K. and Koehnlein, M. and Schuelke, M. and Luedemann, L. and Schmidt, H.H.
Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF.
Diers, A. and Carl, M. and Stoltenburg-Didinger, G. and Vorgerd, M. and Spuler, S.
Interdisziplinaere Leitlinien zur Diagnostik und Therapie der extrazerebralen Amyloidosen: Herausgegeben von der Deutschen Gesellschaft fuer Amyloid-Krankheiten e. V. (www.amyloid.de) [Interdisciplinary guidelines for diagnosis and therapy of extracerebral amyloidosis: issued by the German Society of Amyloid Diseases e. V. (www.amyloid.de)].
Roecken, C. and Ernst, J. and Hund, E. and Michels, H. and Perz, J. and Saeger, W. and Sezer, O. and Spuler, S. and Willig, F. and Schmidt, H.H.
Interdisziplinaere Leitlinien zur Diagnostik und Therapie der extrazerebralen Amyloidosen -- Herausgegeben von der Deutschen Gesellschaft fuer Amyloid-Krankheiten e.V. (www.amyloid.de) [Interdisciplinary guidelines on diagnosis and treatment for extracerebral amyloidoses--published by the German Society of Amyloid Diseases (www.amyloid.de)].
Röcken, C. and Ernst, J. and Hund, E. and Michels, H. and Perz, J. and Saeger, W. and Sezer, O. and Spuler, S. and Willig, F. and Schmidt, H.H.
Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.
Wenzel, K. and Carl, M. and Perrot, A. and Zabojszcza, J. and Assadi, M. and Ebeling, M. and Geier, C. and Robinson, P.N. and Kress, W. and Osterziel, K.J. and Spuler, S.
Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor/CD55 in dysferlin-deficient muscular dystrophy.
Wenzel, K. and Zabojszcza, J. and Carl, M. and Taubert, S. and Lass, A. and Harris, C.L. and Ho, M. and Schulz, H. and Hummel, O. and Huebner, N. and Osterziel, K.J. and Spuler, S.
Long-term treatment experience in a subject with Dunnigan-type familial partial lipodystrophy: efficacy of rosiglitazone.
Luedtke, A. and Heck, K. and Genschel, J. and Mehnert, H. and Spuler, S. and Worman, H.J. and Schmidt, H.H.
A new LMNA mutation causing limb girdle muscular dystrophy 1B.
Spuler, S. and Geier, C. and Osterziel, K.J. and Gutberlet, M. and Genschel, J. and Lehmann, T.N. and Zinn-Justin, S. and Gilquin, B. and Schmidt, H.
Kardiale Manifestationen bei Muskeldystrophien [Cardiac manifestations of muscular dystrophies].
Perrot, A. and Spuler, S. and Geier, C. and Dietz, R. and Osterziel, K.J.
Differenzialdiagnostik eines kongenitalen myasthenen Syndroms [Differential congenital myasthenia syndrome diagnosis].
Spuler, S. and Lehmann, T.N. and Engel, A.G.
Highly purified oligo-His tagged human recombinant alpha(1)-AChR is immunogenic in vivo and suitable for T cell stimulation in vitro in experimental and human myasthenia gravis.
Voltz, R. and Kamm, C. and Padberg, F. and Malotka, J. and Kerschensteiner, M. and Spuler, S. and Tzartos, S. and Dornmair, K.
Multiple sclerosis: longitudinal measurement of interleukin-1 receptor antagonist.
Voltz, R. and Hartmann, M. and Spuler, S. and Scheller, A. and Mai, N. and Hohlfeld, R. and Yousry, T.
Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity.
Spuler, S. and Yousry, T. and Scheller, A. and Voltz, R. and Holler, E. and Hartmann, M. and Wick, M. and Hohlfeld, R.
Thymoma-associated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice.
Spuler, S. and Sarropoulos, A. and Marx, A. and Hohlfeld, R. and Wekerle, H.
Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.
Filippi, M. and Yousry, T. and Campi, A. and Kandziora, C. and Colombo, B. and Voltz, R. and Martinelli, V. and Spuler, S. and Bressi, S. and Scotti, G. and Comi, G.
The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis.
Hohlfeld, R. and Meinl, E. and Weber, F. and Zipp, F. and Schmidt, S. and Sotgiu, S. and Goebels, N. and Voltz, R. and Spuler, S. and Iglesias, A.
Myogenesis in thymic transplants in the severe combined immunodeficient mouse model of myasthenia gravis. Differentiation of thymic myoid cells into striated muscle cells.
Spuler, S. and Marx, A. and Kirchner, T. and Hohlfeld, R. and Wekerle, H.
Aktuelle Therapie der multiplen Sklerose: Mitoxantron [Current therapy of multiple sclerosis: mitoxantrone].
Spuler, S. and Hohlfeld, R.
Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
Meinl, E. and Weber, F. and Drexler, K. and Morelle, C. and Ott, M. and Saruhan-Direskeneli, G. and Goebels, N. and Ertl, B. and Jechart, G. and Giegerich, G. and Schoenbeck, S. and Bannwarth, W. and Wekerle, H. and Hohlfeld, R.
Transplantation of myasthenia gravis thymus to SCID mice.
Schoenbeck, S. and Padberg, F. and Marx, A. and Hohlfeld, R. and Wekerle, H.
Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis.
Schoenbeck, S. and Padberg, F. and Hohlfeld, R. and Wekerle, H.
This list was generated on Fri Apr 19 02:24:43 2019 CEST.

References: V.

 V.

 V.

 V. 
 V.

 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.

 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.